Eli Lilly trial update on kidney drug hurts Tectonic
by
Contributor since / Followers
Contributor since / Followers
2 days ago
Baris-Ozer Shares of Tectonic Therapeutic (NASDAQ:TECX) plunged on Tuesday after a federal website on clinical
LLY
Novo Nordisk’s Ozempic gets FDA approval for kidney disease
by
Contributor since / Followers
Contributor since / Followers
2 days ago
hapabapa Novo Nordisk (NVO) said its popular diabetes drug Ozempic, also known as semaglutide, has
Obesity drug developer Metsera sets terms for $275M IPO
by
Contributor since / Followers
Contributor since / Followers
3 days ago
2d illustrations and photos/iStock via Getty Images Metsera (MTSR), which is developing ultra-long-acting drugs for
Novo Nordisk settles Minnesota insulin pricing case: report
by
Contributor since / Followers
Contributor since / Followers
3 days ago
Victor Golmer Novo Nordisk (NVO) has reportedly settled a lawsuit filed by the state of
Pfizer succeeds in late-stage trial for colorectal cancer therapy
by
Contributor since / Followers
Contributor since / Followers
5 days ago
Md Saiful Islam Khan Pfizer (NYSE:PFE) announced Saturday that its colorectal cancer therapy Braftovi, as
Novo Nordisk spikes as novel obesity drug causes up to 22% of weight loss
by
Contributor since / Followers
Contributor since / Followers
6 days ago
hapabapa/iStock Editorial via Getty Images Novo Nordisk (NVO) shares traded sharply higher in European trading
Allurion stock soars 70% on weight-loss therapy update
by
Contributor since / Followers
Contributor since / Followers
7 days ago
Michail_Petrov-96 Shares of Allurion (NYSE:ALUR) soared 70% in post-market trading Thursday after ending the regular
BofA adds Booz Allen Hamilton and Datadog to its US 1 List
by
Contributor since / Followers
Contributor since / Followers
1 week ago
Richard Drury Bank of America Securities added Booz Allen Hamilton Holding Corp. (NYSE:BAH) and Datadog
Top SA Quant-rated medical devices stocks as technicals look strong
by
Contributor since / Followers
Contributor since / Followers
1 week ago
Tom Werner Medical devices stocks are in a strong position “and must be bought,” according
GLP-1 weight loss drugs linked to a wide range of health benefits and risks: study
by
Contributor since / Followers
Contributor since / Followers
1 week ago
Carolina Rudah A new peer-reviewed study based on data from nearly 2M individuals highlights a